145 related articles for article (PubMed ID: 33005818)
1. Paraneoplastic acute exudative polymorphous vitelliform maculopathy improved with intravitreal methotrexate.
Gao J; Panse K; Foster CS; Anesi SD
Am J Ophthalmol Case Rep; 2020 Dec; 20():100930. PubMed ID: 33005818
[TBL] [Abstract][Full Text] [Related]
2. Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis.
Koreen L; He SX; Johnson MW; Hackel RE; Khan NW; Heckenlively JR
Arch Ophthalmol; 2011 Jan; 129(1):23-9. PubMed ID: 21220625
[TBL] [Abstract][Full Text] [Related]
3. Acute exudative polymorphous paraneoplastic vitelliform maculopathy (AEPPVM) associated with choroidal melanoma.
Gameiro Filho AR; Sturzeneker G; Rodriguez EEC; Maia A; Morales MC; Belfort RN
Int J Retina Vitreous; 2021 Apr; 7(1):27. PubMed ID: 33795031
[TBL] [Abstract][Full Text] [Related]
4. Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report.
Lambert I; Fasolino G; Awada G; Kuijpers R; Ten Tusscher M; Neyns B
BMC Ophthalmol; 2021 Jun; 21(1):250. PubMed ID: 34090381
[TBL] [Abstract][Full Text] [Related]
5. A case of recurring acute exudative polymorphous vitelliform maculopathy successfully treated with intravitreal Ozurdex injection.
Lodhia V; Robson AG; Khoda S; Lee H; Hughes E
Eur J Ophthalmol; 2024 Jan; 34(1):NP90-NP95. PubMed ID: 37350018
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy.
Scupola A; Abed E; Sammarco MG; Traina S; Villano A; Grimaldi G; Blasi MA
Eur J Ophthalmol; 2014; 24(5):803-7. PubMed ID: 24803155
[TBL] [Abstract][Full Text] [Related]
7. Eight-year multimodal follow-up of recurrent idiopathic acute exudative polymorphous vitelliform maculopathy.
Astakhov YS; Astakhov SY; Lisochkina AB; Nechiporenko PA
J Fr Ophtalmol; 2020 Jun; 43(6):500-516. PubMed ID: 32147214
[TBL] [Abstract][Full Text] [Related]
8. THE ROLE OF CHECKPOINT INHIBITORS IN PARANEOPLASTIC ACUTE EXUDATIVE POLYMORPHOUS VITELLIFORM MACULOPATHY: REPORT OF TWO CASES.
Kemels D; Ten Berge JCEM; Jacob J; Schauwvlieghe PP
Retin Cases Brief Rep; 2022 Sep; 16(5):614-618. PubMed ID: 32740323
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic Acute Exudative Polymorphous Vitelliform Maculopathy: Clinical Spectrum and Multimodal Imaging Characteristics.
Barbazetto I; Dansingani KK; Dolz-Marco R; Giovannini A; Piccolino FC; Agarwal A; Lima LH; Vianna RN; Yannuzzi LA
Ophthalmology; 2018 Jan; 125(1):75-88. PubMed ID: 28844323
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus Disease 2019-induced Acute Exudative Polymorphous Vitelliform Maculopathy.
Osman M; Mehana O; Eissa M; Zeineldin S; Sinha A
Middle East Afr J Ophthalmol; 2022; 29(4):235-237. PubMed ID: 38162565
[TBL] [Abstract][Full Text] [Related]
11. Electrooculogram (EOG) findings in a case of acute exudative polymorphous vitelliform maculopathy (AEPVM) detected following trauma.
Lee RM; Robson AG; Hughes EH
Doc Ophthalmol; 2013 Dec; 127(3):255-9. PubMed ID: 24052225
[TBL] [Abstract][Full Text] [Related]
12. ACUTE EXUDATIVE PARANEOPLASTIC POLYMORPHOUS VITELLIFORM MACULOPATHY DURING VEMURAFENIB AND PEMBROLIZUMAB TREATMENT FOR METASTATIC MELANOMA.
Sandhu HS; Kolomeyer AM; Lau MK; Shields CL; Schuchter LM; Nichols CW; Aleman TS
Retin Cases Brief Rep; 2019 Spring; 13(2):103-107. PubMed ID: 28614138
[TBL] [Abstract][Full Text] [Related]
13. Acute Exudative Polymorphous Paraneoplastic Vitelliform Maculopathy Managed With Intravitreal Aflibercept.
Gündüz K; Çöndü G; Shields CL
Ophthalmic Surg Lasers Imaging Retina; 2017 Oct; 48(10):844-850. PubMed ID: 29020430
[TBL] [Abstract][Full Text] [Related]
14. Clinical Correlation between Acute Exudative Polymorphous Paraneoplastic Vitelliform Maculopathy and Metastatic Melanoma Disease Activity: A 48-month Longitudinal Case Report.
Mueller CM; Hojjatie SL; Lawson DH; Jain N; Robinson J; Khan MK; Yushak ML; A Datoo O'Keefe G
Ocul Immunol Inflamm; 2022 Feb; 30(2):330-337. PubMed ID: 33021420
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 VACCINE-INDUCED ACUTE EXUDATIVE POLYMORPHOUS VITELLIFORM MACULOPATHY: CASE REPORTS.
Baddar D; Fayed AE; Tawfik CA; Bassily S; Gergess MM; El-Agha MH
Retin Cases Brief Rep; 2024 Jan; 18(1):66-70. PubMed ID: 36731098
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies Against Bestrophin in Non-Paraneoplastic Acute Exudative Polymorphous Vitelliform Maculopathy.
Pan WW; Tracey BM; Jayasundera KT; Fahim AT
Ophthalmic Surg Lasers Imaging Retina; 2024 Jan; 55(1):51-54. PubMed ID: 38189803
[TBL] [Abstract][Full Text] [Related]
17. Acute exudative polymorphous vitelliform maculopathy: To bolus or not to bolus?
Grenga PL; Fragiotta S; Cutini A; Vingolo EM
Oman J Ophthalmol; 2018; 11(3):280-283. PubMed ID: 30505125
[TBL] [Abstract][Full Text] [Related]
18. Acute exudative polymorphous vitelliform maculopathy in a young man: a case report.
Modi KK; Roth DB; Green SN
Retin Cases Brief Rep; 2014; 8(3):200-4. PubMed ID: 25372438
[TBL] [Abstract][Full Text] [Related]
19. Atypical unilateral maculopathy associated with acute exudative polymorphous vitelliform maculopathy-like yellowish deposits.
Bruè C; Barbazetto I; Markomichelakis NN; Yannuzzi LA; Bailey Freund K; Kotsolis AI
Retin Cases Brief Rep; 2012; 6(2):135-8. PubMed ID: 25390943
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic acute exudative polymorphous vitelliform maculopathy: the importance of multimodal imaging, systemic workup and genetic testing.
Fernandes JS; Gomes PP; Neves P; Marques JP
BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37380373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
